CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-05 | Shames Richard S. Chief Medical Officer | Option exercise · Stock Option (right to buy) | −2,017 | 36,802 | ||
| 2017-09-12 | Shames Richard S. Chief Medical Officer | Sale | −3,687 | $14.31 | $53K | 0 |
| 2017-08-29 | Shames Richard S. Chief Medical Officer | Option exercise | +1,512 | $4.21 | $6K | 3,377 |
| 2017-08-29 | Shames Richard S. Chief Medical Officer | Sale | −1,512 | $17.00 | $26K | 1,865 |
| 2017-08-29 | Shames Richard S. Chief Medical Officer | Option exercise · Stock Option (right to buy) | −1,512 | 38,819 | ||
| 2017-08-28 | Liu David Y Chief Scientific Officer | Option exercise | +3,500 | $4.21 | $15K | 5,500 |
| 2017-08-28 | Liu David Y Chief Scientific Officer | Sale | −3,500 | $15.00 | $53K | 2,000 |
| 2017-08-28 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −3,500 | 42,331 | ||
| 2017-07-10 | Liu David Y Chief Scientific Officer | Option exercise | +3,500 | $1.89 | $7K | 5,500 |
| 2017-07-10 | Liu David Y Chief Scientific Officer | Sale | −3,500 | $12.68 | $44K | 2,000 |
| 2017-07-10 | Liu David Y Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −3,500 | 16,725 | ||
| 2017-06-15 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2017-05-25 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-05-25 | Shanafelt Armen Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-05-25 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-05-25 | KHOSLA CHAITAN PHD Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-05-25 | Papanek Julie Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-05-16 | Giraudo Bryan Director | Purchase | +10,000 | $6.46 | $65K | 10,000 |
| 2017-05-09 | PATEL DINESH V PH D President and CEO | Option exercise | +19,099 | $1.16 | $22K | 190,437 |
| 2017-05-09 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −19,099 | 78,203 |
Page 27 of 29 · 580 trades